chr11-64890927-G-C
Variant names:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000413053.2(MIR194-2HG):n.2280C>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0394 in 243,176 control chromosomes in the GnomAD database, including 300 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.040 ( 173 hom., cov: 31)
Exomes 𝑓: 0.039 ( 127 hom. )
Consequence
MIR194-2HG
ENST00000413053.2 non_coding_transcript_exon
ENST00000413053.2 non_coding_transcript_exon
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.75
Genes affected
MIR194-2HG (HGNC:51946): (MIR194-2 host gene)
MIR192 (HGNC:31562): (microRNA 192) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0536 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MIR194-2HG | ENST00000413053.2 | n.2280C>G | non_coding_transcript_exon_variant | Exon 2 of 2 | 2 | |||||
MIR194-2HG | ENST00000710929.1 | n.391-1587C>G | intron_variant | Intron 3 of 3 | ||||||
MIR194-2HG | ENST00000710930.1 | n.551+1502C>G | intron_variant | Intron 3 of 3 | ||||||
MIR192 | ENST00000384915.3 | n.*210C>G | downstream_gene_variant | 6 |
Frequencies
GnomAD3 genomes AF: 0.0400 AC: 6082AN: 152132Hom.: 173 Cov.: 31
GnomAD3 genomes
AF:
AC:
6082
AN:
152132
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0386 AC: 3507AN: 90926Hom.: 127 Cov.: 0 AF XY: 0.0354 AC XY: 1791AN XY: 50602
GnomAD4 exome
AF:
AC:
3507
AN:
90926
Hom.:
Cov.:
0
AF XY:
AC XY:
1791
AN XY:
50602
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0399 AC: 6081AN: 152250Hom.: 173 Cov.: 31 AF XY: 0.0413 AC XY: 3071AN XY: 74430
GnomAD4 genome
AF:
AC:
6081
AN:
152250
Hom.:
Cov.:
31
AF XY:
AC XY:
3071
AN XY:
74430
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
31
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at